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aBstraCt
BaCKground: Ocular medulloepithelioma (OM) is a rare ocular malignancy. This is a report of a rare case of 
medulloepithelioma that was misdiagnosed as retinoblastoma.
Material and Methods: A case report and review of published, peer-reviewed, English language literature 
reporting on ocular medulloepithelioma. 
results: A seven-year-old girl presented with a white mass in the anterior chamber of her left eye. The initial 
diagnosis was retinoblastoma with anterior chamber invasion, and therefore it was enucleated. Microscopy showed 
a cellular tumour composed of malignant primitive cells forming sheets, rosettes, and tubular structures. Based on 
the presence of prominent pleomorphism the tumour was diagnosed as malignant teratoid medulloepithelioma.  
At last date of follow-up three years after enucleation, the patient was alive without metastasis. A systematic review 
of literature, analysed 177 cases of OM. The tumour was localised in the ciliary body in 134 (92%) cases, and 26 
(23%) cases had extraocular extension. Primary management was enucleation in 84 (55%) cases, tumour resection 
in 32 (21%) cases, and radiation therapy in 20 (13%) cases. Histopathology disclosed benign features in 36 (22%) 
eyes, malignant features in 124 (78%) eyes, teratoid features in 72 (59%), and non-teratoid features in 51 (41%) 
eyes. At a mean follow-up of five years, 14 (8%) patients had metastasis, and six (6%) patients were dead. 
ConClusions: Ocular medulloepithelioma most commonly affects children. The most common type is the malig-
nant teratoid type, but it has a favourable prognosis, and distant metastasis and mortality are relatively rare, at 8% 
and 6%, respectively.
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introduCtion
Ocular medulloepithelioma (OM) is a rare em-
bryonal tumour arising from the primitive medul-
lary epithelium, along the inner layer of the optic 
cup [1–3]. It arises from the ciliary body from the 
non-pigmented ciliary epithelium of the pars plica-
ta, and rarely in the iris, retina, or optic nerve head 
[3–5]. This tumour is similar to medulloepithe-
lioma of the central nervous system, but intraocular 
medulloepithelioma rarely affects adults and usu-
ally affects the ciliary body in children (median age 
3.8 years; range 6 months to 41 years) [6–8]. Ocu-
lar medulloepithelioma is a non-hereditary tumour, 
but it can be a manifestation of a tumour predispo-
sition syndrome associated with DICER1-related 
pleuro-pulmonary blastoma [9–11]. Ocular medul-
loepithelioma was named diktyoma in 1908 due to 
the presence of a network of medullary epithelial 
bands in this tumour, and in 1931 the term medul-
loepithelioma was introduced, and this has been the 
favoured terminology since then [12, 13]. 
Features of malignancy in OM are not well de-
fined. They include the presence of sheets of poorly 
differentiated neuroblastic cells, involvement of 
ocular and extra ocular tissue, the presence of sar-
comatous features, and the degree of mitotic activ-
ity and pleomorphism, and they are classified into 
non-teratoid or teratoid type, and benign or malig-
nant [1, 2, 6–8]. Of two relatively large case series 
of medulloepithelioma in the literature (56 cases 
by Broughton and Zimmerman [7], and 41 cases 
by Kaliki et al. [10]), 50–63% were non-teratoid, 
37–50% were teratoid, and around 80% were of 
malignant type. Herein we report a case of medul-
loepithelioma in a seven-year-old girl, as well as 
a systematic review of the published literature about 
ocular medulloepithelioma to summarise the re-
ported clinical and histopathological features, treat-
ments, and outcome of OM. 
Material and Methods
A search of the published, peer-reviewed litera-
ture reporting on ocular medulloepithelioma by 
MEDLINE search with key words “Medulloepithe-
lioma, Ciliary body tumor, Ocular tumor” was con-
ducted up to March 2017. We also examined the 
reference lists of the reports. We analysed in detail 
all case series and case reports that described ocular 
medulloepithelioma. We excluded all cases with any 
diagnosis other than medulloepithelioma as well as 
reports in languages other than English for which 
a translation was not available. Outcome measures 
included: demographics, presentation, clinical fea-
tures, histopathologic features (benign vs. malignant 
and teratoid vs. non teratoid), extent of the disease, 
therapeutic interventions, management outcome, 
site of metastasis, and survival data.
For the sake of calculating the percentage for 
any outcome in this analysis when the outcome 
measure was not available for the group of patients, 
we referred the percentage to the number of pa-
tients with known outcome, excluding those with 
unknown outcome.
results
A review of Medline literature before March 
2017 identified 205 cases of intra ocular medul-
loepithelioma. We included the cases we are report-
ing here, and we excluded 10 cases from articles not 
in English language and 17 cases because of possible 
duplication or inadequate data for analysis. The 
overall number of cases eligible for analysis was 177.
Case report
A seven-year-old girl, who was diagnosed with 
glaucoma at the age of two years and had a drain-
age device inserted at the age of four years, pre-
sented with a white mass in the anterior chamber 
of her left eye (Fig. 1). The initial diagnosis was 
retinoblastoma with anterior chamber invasion 
vs. medulloepithelioma, and therefore it was enu-
cleated. The enucleated eye showed a 2.1 × 1.2 cm 
grey-white tumour located mainly in the anterior 
chamber. A plastic glaucoma drainage device was 
attached to the eye. Microscopy showed a cel-
lular tumour composed of malignant primitive 
cells forming sheets, rosettes, and tubular struc-
Figure 1. a. Left eye presented with leukocoria due to presence 
of retrolental cyclitic membrane associated with anterior cham-
ber invasion of this white mass superiorly. B. Right eye showed 
normal fundus exam. Initial diagnosis was retinoblastoma with 
anterior chamber invasion vs. medulloepithelioma
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tures. The tumour exhibited numerous mitotic 
figures with prominent pleomorphism and areas 
of necrosis (Fig. 2). It also harboured heterotopic 
elements in the form of astrocytic tissue and a few 
foci of cartilage. No sarcomatous features were 
present. The tumour cells were positive for synap-
tophysin. EMA was focally positive with a lumi-
nal pattern. GFAP was positive in the astrocytic 
component. The Ki-67 labelling index was around 
80% (Fig. 2). Most of the tumour was located 
in the anterior chamber with involvement of the 
vitreous, cornea, and sclera. The optic nerve and 
disc were free of tumour. Based on the presence of 
heterotopic elements, primitive neuroblastic dif-
ferentiation, invasion of the sclera and cornea, 
numerous mitotic figures, and prominent pleo-
morphism, the tumour was diagnosed as malig-
nant teratoid medulloepithelioma. At last date of 
follow-up three years after enucleation, the patient 
was alive without metastasis.
patients and CliniCal CharaCteristiCs
Out of 177 patients analysed in this review, there 
were 72 males (49% of 148 with reported gender) 
and 76 females (51%); the mean age at time of 
diagnosis was nine years (range, 1–79 years); only 
18 (10%) patients were diagnosed after the age of 
10 years. The presentation was variable between the 
reported cases. Fifty-three (56% of 94 with report-
ed presentation) patients presented with leukocoria 
or intraocular mass, eight (9%) patients presented 
with proptosis, eight (9%) patients presented with 
squint, eight (9%) patients presented with buph-
thalmos, 14 (15%) patients presented with eye pain, 
and three (3%) patients were diagnosed inciden-
tally. In 83 (47% – the percentage here is confusing 
because it makes the sum 147%, so I prefer not to 
mention the percentage) patients the presentation 
was not mentioned (Tab. I). The tumour was in 
the ciliary body in 134 (92%) cases, in the retina 
in four (3%) cases, in the optic nerve in eight (5%) 
cases, while it was not mentioned in the remaining 
31 (18%) patients. Extraocular tumour extension 
was reported in 26 (23% of 114 cases), and no 
extraocular tumour extension was seen in 88 (77%) 
cases, while it was not mentioned in the remaining 
63 (36%) cases (Tab. II). 
pathologiC CharaCteristiCs
Regarding tumour pathologic features; 124 (78%) 
eyes harboured malignant tumours, and 36 (22%) 
eyes harboured benign tumours, while it was 
not mentioned in the remaining 17 (10%) pa-
tients. Seventy-two (59%) tumours were of teratoid 
type, 51 (41%) were of non-teratoid type, and the 
type was not mentioned in the remaining 54 (31%) 
patients. Out of the 36 benign tumours, 12 (39%) 
were teratoid and 19 (61%) were non-teratoid, and 
out of the 124 malignant tumours, 60 (65%) were 
teratoid and 32 (35%) were non-teratoid. In five 
(14%) of the benign tumours and 32 (26%) of the 
Figure 2. Medulloepithelioma was diagnosed based on mi-
croscopy that showed cellular tumour composed of epithelium, 
glial tissue (a), and tubular structures (B). The tumour exhibited 
numerous mitotic figures with prominent pleomorphic of poorly 
differentiated neuroepithelium (C), few foci of cartilage (d), scle-
ral invasion (e), and necrosis (F). The tumour cells were positive 
for synaptophysin (g) and GFAP in the astrocytic component (h). 
EMA was focally positive with a luminal pattern (i), and the Ki67 
LI was around 80% (J)
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Table I. Patients’ demographics
    Number % Adjusted* %
Number 177
Age Mean 9 years
  Range 1–79 years
Gender Male 72 41 49
  Female 76 43 51
  NA** 29 16 -
Presentation Mass or leukocoria 53 30 56
  Proptosis 8 5 9
  Buphthalmos 8 5 9
  Squint 8 5 9
  Accidental 3 2 3
  Pain 14 8 15
  NA** 83 47 -
* For the sake of calculating the percentage for any outcome in this analysis when the outcome measure was not available for group of the patients, we referred the percentage to the 
number of patients with known outcome, excluding those with unknown outcome; **NA — these outcome data were not reported in the original article reporting about these patients
Table II. Tumour features and management outcome
    Number % Adjusted* %
Location Ciliary body 134 76 92
  Retina 4 2 3
  Optic nerve 8 5 5
  NA** 31 18 -
Extraocular extension No 88 50 77
  Yes 26 15 23
  NA** 63 36 -
Pathology Teratoid 72 41 59
  Non Teratoid 51 29 41
  NA** 54 31 -
  Benign 36 20 22
  Teratoid 12 33 39
Non Teratoid 19 53 61
NA** 5 14 -
Malignant 124 70 78
Teratoid 60 48 65
Non Teratoid 32 26 35
NA** 32 26 -
NA** 17 10 -
*For the sake of calculating the percentage for any outcome in this analysis when the outcome measure was not available for group of the patients, we referred the percentage to the 
number of patients with known outcome, excluding those with unknown outcome; **NA — these outcome data were not reported in the original article reporting about these patients
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malignant tumours, the teratoid vs. non-teratoid type 
was not mentioned. No patients in this review had 
a family history of medulloepithelioma, and all of 
them had unilateral disease (Tab. II).
ManageMent and outCoMe
The primary treatment of the reported eyes was 
variable between different reports; 84 eyes (55%) 
were treated by enucleation, 32 eyes (21%) by tu-
mour resection, 21 (13%) by radiation (15 eyes 
by radioactive plaque therapy, five eyes by external 
beam radiation therapy), and seven eyes were treat-
ed by exenteration. The primary treatment was not 
mentioned for 24 (14%) eyes (Tab. III). At a mean 
follow-up of five years (range 1–25 years), out of the 
81 eyes for which the status of the eye globe was de-
scribed, 56 (69%) eyes were salvaged, and 25 (31%) 
eyes were not. At the last date of follow-up, 14 (8%) 
patients were reported to have metastasis, and six 
(6%) patients were dead. One had bone metastasis, 
nine had lymphatic metastasis to the neck (four of 
them were in the parotid gland), and the site of me-
tastasis was not mentioned in eight cases.
disCussion
Similar to retinoblastoma, which is the most 
common intraocular malignant tumour in chil-
dren, 90% of cases are diagnosed before the age of 
five years [14]. Medulloepithelioma is another rare 
childhood disease. Kaliki et al. [10], in an analysis 
of 41 cases of OM from the USA and India, found 
that 85% of patients were children; similarly, in 
our systematic review of 177 patients including the 
41 patients described in that study, the mean age at 
diagnosis was nine years, which is older than the age 
of diagnosis of retinoblastoma. However, the pos-
sibility of medulloepithelioma still exists in adults 
[10, 15–18]. It is not known if this later diagnosis of 
OM compared to retinoblastoma is due to delayed 
Table III. Management and outcome
    Number % Adjusted* %
Primary Treatment Enucleation 84 47 55%
  Tumour resection 32 18 21%
  Plaque radiotherapy 15 8 10%
  External beam 
radiotherapy
5 3 3%
  Others** 17 10 11%
  NA*** 24 14 –
 
Eye Salvage Yes 56 32 69%
  NO 25 14 31%
NA*** 121 68 –
Metastasis No 152 86 92%
  Yes 14 8 8%
  NA*** 11 6 –
Mortality Alive 91 51 94%
  Dead 6 3 6%
  NA*** 63 36 –
Follow up Mean 5 years  
  Range 1–25 years
*For the sake of calculating the percentage for any outcome in this analysis when the outcome measure was not available for group of the patients, we referred the percentage to the 
number of patients with known outcome, excluding those with unknown outcome; **Others: cryotherapy in 5 cases, palliative chemotherapy in 5 cases, and exenteration in 7 cases; 
***NA — these outcome data were not reported in the original article reporting about these patients
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event of tumour initiation or due to delayed diag-
nosis. Most cases of OM present due to associated 
secondary effects on the eye like glaucoma (44% to 
60%) or a drop in vision due to a cataract (26% to 
50%), or a mass obstructing the visual access [6, 10, 
19, 20]. In our review, half of the cases presented 
with a large mass causing leukocoria, which indi-
cates a large, long-standing tumour. Therefore, it 
is believed that the later age of diagnosis of medul-
loepithelioma may be due to the difficulty in di-
rectly visualising the ciliary body mass because of its 
anatomical location until it produces clinically de-
tectable side effects. In addition to that, initial mis-
management of ciliary body medulloepithelioma is 
common, which may result in delayed diagnosis [6, 
20, 21]. The differential diagnosis includes other 
malignant ocular tumours such as retinoblastoma 
and malignant melanoma, in addition to secondary 
involvement by extraocular tumours such as Ewing’s 
sarcoma/PNET, rhabdomyosarcoma, and neurob-
lastoma. In our case report, the patient was mis-
diagnosed initially as atypical retinoblastoma with 
anterior chamber and ciliary body invasion, and the 
diagnosis of medulloepithelioma was pathological. 
Medulloepithelioma displays a unique propen-
sity to produce a retrolental neoplastic cyclitic mem-
brane that is an extension of the tumour [6, 10]. 
This cyclitic membrane serves as an important fea-
ture to differentiate medulloepithelioma from retin-
oblastoma and Coats’ disease. Fluorescein angiog-
raphy shows rapid filling of large, haphazard vessels 
emanating from the ciliary body across the hyaloid 
face in the case of medulloepithelioma, whereas the 
vessels are regular, organised, and emanate from the 
closed central funnel of the detachment out toward 
the ciliary body region in the case of retinoblastoma 
or Coats’ disease [22, 23]. Medulloepithelioma can 
also be confused with persistent hyperplastic pri-
mary vitreous (PHPV) in some cases, but it shows 
a tendency to grow along the scaffold of the hyaloid 
and the retinal surface unlike PHPV [24–26]. On 
the other hand, similar to retinoinvasive melanoma, 
medulloepithelioma can rarely invade the retina, 
and therefore is called retinoinvasive medulloepithe-
lioma mainly in chronic cases in older patients who 
present with glaucoma [27]. 
Features of malignancy in OM are not well de-
fined. They include the presence of sheets of poorly 
differentiated neuroblastic cells resembling those 
of retinoblastoma with or without rosettes; sarco-
matous areas resembling chondrosarcoma, rhab-
domyosarcoma, or embryonal sarcoma, nuclear 
pleomorphism, or mitotic activity; and invasion 
of the uvea, cornea, or sclera with or without ex-
trascleral extension [6, 19], and this is different 
than acquired epithelioma (adenoma or adenocar-
cinoma) of the nonpigmented ciliary epithelium 
that affects adults, and it has no embryonic fea-
tures histopathologically [28]. In our review, only 
18 (10%) patients were diagnosed after the age 
of 10 years. Also, on histopathologic examination, 
non-teratoid medulloepithelioma discloses prolif-
eration of primitive medullary epithelium, whereas 
teratoid medulloepithelioma harbours heteroplas-
tic elements (most frequently hyaline cartilage, in 
addition to rhabdomyoblasts, striated muscle, and 
brain-like tissue) and proliferation of the neuroepi-
thelial elements [1, 10. 19]. In this review, 78% of 
cases were malignant, and 65% of the malignant tu-
mours were teratoid, while only 39% of the benign 
tumours showed a teratoid component.
Treatment options for OM include local resec-
tion, radiation therapy (radioactive plaque therapy 
and external beam radiotherapy), enucleation, and 
rarely exenteration [6, 8, 19, 30, 31]. The role of 
systemic chemotherapy in the treatment of OM is 
not well established [32]. In our review, enuclea-
tion was the treatment modality for more than half 
of the cases, followed by local resection in 21% 
of cases. However, plaque radiotherapy (apex dose 
of 40 Gy) was used with a high success rate in 
10% of cases. Local resection can be considered for 
small circumscribed tumours (less than three clock 
hours), but the tumour recurrence rate is high for 
large tumours (50–100%) [8, 10, 19]. This high 
recurrence rate may be due to the presence of thin 
membranes of tumour cells, which are invisible in-
traoperatively, as we mentioned before.
Because of the rarity of OM, limited data are 
available about its prognosis. The prognosis of OM 
depends on the origin of the tumour, extraocu-
lar extension, and intracranial extension, and it 
is better for ciliary medulloepithelioma without 
extraocular or intracranial extension [1, 4]. Ocular 
medulloepithelioma has a known systemic associa-
tion with pleuropulmonary blastoma. It is postu-
lated that 1% of patients with pleuropulmonary 
blastoma develop OM, and 5% of patients with 
medulloepithelioma have a history of pleuropul-
monary blastoma [10, 11]. Similarly to our data, 
metastatic disease from ciliary body medulloepi-
thelioma was reported in 8% of cases, most of 
which had extraocular tumour extension [6, 9, 10, 
19]. Khaliki et al. described three cases with me-
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tastasis, all of which presented with extraocular 
tumour extension into the conjunctiva or the orbit. 
In contrary to metastatic retinoblastoma, which 
most commonly affect the brain and/or the bone 
marrow [33], metastatic medulloepithelioma is to 
the lymphatics in 90% of cases.
ConClusion 
In conclusion, ciliary body medulloepithelioma 
is a rare unilateral disease that affects children, and 
it usually presents with leukocoria or an intraocular 
mass that can be misdiagnosed as retinoblastoma, 
Coats’ disease, or PHPV. Enucleation is the most 
popular treatment for large tumours, even though 
tumour resection and radiation therapy may play 
a role in the management small tumours. Medul-
loepithelioma-associated mortality is rare and usu-
ally associated with extraocular tumour extension 
and metastasis toward lymphatics.
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